Ahrens Investment Partners’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$10K 1061
2021
Q4
$10K Buy
+100
New +$10.3K ﹤0.01% 742

Other funds holding GH

Ahrens Investment Partners's GH Position: Q1 2022 in Review

Ahrens Investment Partners sold out of Guardant Health (GH) in Q1 2022, closing a stake of 100 shares — an estimated $10K sold.

Ahrens Investment Partners first reported a position in GH in Q4 2021 and held it in 1 quarter. The position peaked at $10K in Q4 2021. 355 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • Ahrens Investment Partners reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • Ahrens Investment Partners sold 100 Guardant Health shares in Q1 2022, an estimated $10K.
  • Ahrens Investment Partners first reported a position in Guardant Health in Q4 2021 and held it in 1 quarter.
  • Ahrens Investment Partners's Guardant Health position peaked at $10K in Q4 2021.
  • 355 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Ahrens Investment Partners's 13F filing for Q1 2022, filed 28 Apr 2022.